Pharmacological profile of CEB-1957 and atropine toward brain muscarinic receptors and comparative study of their efficacy against sarin poisoning

Toxicology and Applied Pharmacology

Volumn 150, Issue 2, 1998, Pages 321-327

  Trovero, Fabrice ^a   Brochet, Denis ^a   Breton, Patrick ^b   Tambuté, André ^b   Bégos, Arlette ^b   Bizot, Jean Charles ^b  

^a Psypharm SA   (France)

^b CENTRE D ETUDES DU BOUCHET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOHEXYL 2 HYDROXY 2 (3 THIENYL)ACETIC ACID 3 DIMETHYLAMINOPROPYL ESTER; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; CEB 1957; CHOLINESTERASE INHIBITOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; PIRENZEPINE; PRALIDOXIME MESILATE; RECEPTOR SUBTYPE; SARIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; INTOXICATION; INTRAMUSCULAR DRUG ADMINISTRATION; LETHALITY; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0032103337     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8423     Document Type: Article

References (36)

1. 3. Eur. J. Pharmacol. 217:1992;173-184.
2. Bizot, J.-C. Koch, B. Edvinson, A. Falcy, C. Larsson, R. 1998, Comparison of atropine and CEB-1957 for undesirable side effects and for therapeutic efficacy against soman given by inhalation route.
3. Bonner T. I., Buckley N. J., Young A. C., Brann M. R. Identification of a family of muscarinic acetylcholine receptor genes. Science (Washington, DC). 237:1987;527-532.
4. Bonner T. I., Young A. C., Brann M. R., Buckley N. J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1:1988;403-410.
5. Brimblecombe R. W., Green D. M., Stratton J. A., Thompson P. B. The protective action of some anticholinergic drugs in sarin poisoning. Br. J. Pharmacol. 39:1970;609-616.
6. Brown J. E. Atropine, scopolamine and related antimuscarinic drugs. Goodman and Gilman's the Phamacological Basis of Therapeutics. 1990;Pergamon Press, New York. p. 150-165.
7. Buckley N. J., Bonner T. I., Brann M. R. Localization of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8:1988;4646-4652.
8. Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
9. Castellano C. Effects of some anticholinergic drugs on water maze learned behaviour in mice. Psychopharmacologia (Berlin). 21:1971;361-369.
10. 50. Biochem. Pharmacol. 22:1973;3099-3108.
11. Cortes R., Palacios J. M. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Brain Res. 362:1986;227-238.
12. Dawson R. M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14:1994;317-331.
13. Dopke K. L., Vrana K. E., Vogt L. J., Vogt B. A. AF-DX 384 binding in rabbit cingulate cortex: Two site kinetics and section autoradiography. J. Pharmacol. Exp. Ther. 274:1995;562-569.
14. Frey K. A., Howland M. M. Quantitative autoradiography of muscarinic cholinergic receptor binding in the rat brain: Distinction of receptor subtypes in antagonist competition assays. J. Pharmacol. Exp. Ther. 263:1992;1391-1400.
15. Giraldo E., Hammer R., Ladinsky H. Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sci. 40:1987;833-840.
16. Grauer E., Kapon J. Differential effects of anticholinergic drugs on paired discrimination performance. Pharmacol. Biochem. Behav. 53:1996;463-467.
17. Harris L. W., Talbot B. G., Lennox W. J., Anderson D. R., Solana R. P. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication. Drug Chem. Toxicol. 14:1991;265-281.
18. Hulme E. C., Birdsall N. J. M., Buckley N. J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
19. Koenig J. F. R., Klippel R. A. The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brainstem. 1963;Williams and Wilkins, Baltimore.
20. Kubo T., Fukuda K., Mikami A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 323:1986;560-561.
21. Lallement G., Denoyer M., Collet A., Pernot-Marino I., Baubichon D., Monmaur P., Blanchet G. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: Influence of septal cholinoceptive cells. Neurosci. Lett. 139:1992;104-107.
22. Leadbeater L., Inns R. H., Rylands J. M. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5:1985;S225-S231.
23. Litchfield J. T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
24. 33. J. Pharmacol. Exp. Ther. 228:1984;648-655.
25. Mash D. C., Potter L. T. Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain. Neuroscience. 19:1986;551-564.
26. McKinney M., Coyle J. T. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. Mayo Clin. Proc. 66:1991;1225-1237.
27. 3. J. Pharmacol. Exp. Ther. 259:1991;601-607.
28. O'Connell A., Earley B., Leonard B. E. Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochem. Int. 25:1994;243-252.
29. Peralta E. G., Ashkenazi A., Winslow J. W., Smith D. H., Ramachandran J., Capon D. J. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6:1987;3923-3929.
30. Quirion R., Richard J., Wilson A. Muscarinic and nicotinic modulation of cortical acetylcholine release monitered by in vivo microdialysis in freely moving adult rats. Synapse. 17:1994;92-100.
31. Tambuté A., Collet A. Dédoublement et détermination de la configuration absolue des énantiomères de l'acide (thiényl-3)-cyclohexyl-2 hydroxy-2 acétique. Application à la synthèse d'esters anticholinergiques du quinuclidinol-3. Bull. Soc. Chim. Fr. 1-2:1984;77-82.
32. Vannucchi M. G., Pepeu G. Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neurosci. Lett. 190:1995;53-56.
33. Waddington J. L., Olley J. E. Dissociation of the anti-punishment activities of chlordiazepoxide and atropine using two heterogeneous passive avoidance tasks. Psychopharmacology. 52:1977;93-96.
34. Wei J., Walton E. A., Milici A., Buccafusco J. J. mm. J. Neurochem. 63:1994;815-821.
35. 3. Eur. J. Pharmacol. 91:1983;147-149.
36. Zubieta J. K., Frey K. A. Autoradiographic mapping of M3 muscarinic receptors in the rat brain. J. Pharmacol. Exp. Ther. 264:1993;415-422.